These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 23233446)
1. A proteomics and transcriptomics approach to identify leukemic stem cell (LSC) markers. Bonardi F; Fusetti F; Deelen P; van Gosliga D; Vellenga E; Schuringa JJ Mol Cell Proteomics; 2013 Mar; 12(3):626-37. PubMed ID: 23233446 [TBL] [Abstract][Full Text] [Related]
2. High GPR56 surface expression correlates with a leukemic stem cell gene signature in CD34-positive AML. Daga S; Rosenberger A; Quehenberger F; Krisper N; Prietl B; Reinisch A; Zebisch A; Sill H; Wölfler A Cancer Med; 2019 Apr; 8(4):1771-1778. PubMed ID: 30848055 [TBL] [Abstract][Full Text] [Related]
3. Expression of CD44 variant exons in acute myeloid leukemia is more common and more complex than that observed in normal blood, bone marrow or CD34+ cells. Bendall LJ; Bradstock KF; Gottlieb DJ Leukemia; 2000 Jul; 14(7):1239-46. PubMed ID: 10914548 [TBL] [Abstract][Full Text] [Related]
4. Differential antigen expression and aberrant signaling via PI3/AKT, MAP/ERK, JAK/STAT, and Wnt/β catenin pathways in Lin-/CD38-/CD34+ cells in acute myeloid leukemia. Garg S; Shanmukhaiah C; Marathe S; Mishra P; Babu Rao V; Ghosh K; Madkaikar M Eur J Haematol; 2016 Mar; 96(3):309-17. PubMed ID: 26010294 [TBL] [Abstract][Full Text] [Related]
5. Proteomic profiling identifies distinct protein patterns in acute myelogenous leukemia CD34+CD38- stem-like cells. Kornblau SM; Qutub A; Yao H; York H; Qiu YH; Graber D; Ravandi F; Cortes J; Andreeff M; Zhang N; Coombes KR PLoS One; 2013; 8(10):e78453. PubMed ID: 24223100 [TBL] [Abstract][Full Text] [Related]
6. CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia. Hosen N; Park CY; Tatsumi N; Oji Y; Sugiyama H; Gramatzki M; Krensky AM; Weissman IL Proc Natl Acad Sci U S A; 2007 Jun; 104(26):11008-13. PubMed ID: 17576927 [TBL] [Abstract][Full Text] [Related]
7. Delineation of target expression profiles in CD34+/CD38- and CD34+/CD38+ stem and progenitor cells in AML and CML. Herrmann H; Sadovnik I; Eisenwort G; Rülicke T; Blatt K; Herndlhofer S; Willmann M; Stefanzl G; Baumgartner S; Greiner G; Schulenburg A; Mueller N; Rabitsch W; Bilban M; Hoermann G; Streubel B; Vallera DA; Sperr WR; Valent P Blood Adv; 2020 Oct; 4(20):5118-5132. PubMed ID: 33085758 [TBL] [Abstract][Full Text] [Related]
8. CD34⁺/CD38⁻ acute myelogenous leukemia cells aberrantly express CD82 which regulates adhesion and survival of leukemia stem cells. Nishioka C; Ikezoe T; Furihata M; Yang J; Serada S; Naka T; Nobumoto A; Kataoka S; Tsuda M; Udaka K; Yokoyama A Int J Cancer; 2013 May; 132(9):2006-19. PubMed ID: 23055153 [TBL] [Abstract][Full Text] [Related]
9. Aberrant marker expression patterns on the CD34+CD38- stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission. van Rhenen A; Moshaver B; Kelder A; Feller N; Nieuwint AW; Zweegman S; Ossenkoppele GJ; Schuurhuis GJ Leukemia; 2007 Aug; 21(8):1700-7. PubMed ID: 17525725 [TBL] [Abstract][Full Text] [Related]
10. Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: identification of discordant MDR-/efflux+ and MDR1+/efflux- cases. Leith CP; Chen IM; Kopecky KJ; Appelbaum FR; Head DR; Godwin JE; Weick JK; Willman CL Blood; 1995 Sep; 86(6):2329-42. PubMed ID: 7545025 [TBL] [Abstract][Full Text] [Related]
11. Determination of P-glycoprotein, MDR-related protein 1, breast cancer resistance protein, and lung-resistance protein expression in leukemic stem cells of acute myeloid leukemia. de Figueiredo-Pontes LL; Pintão MC; Oliveira LC; Dalmazzo LF; Jácomo RH; Garcia AB; Falcão RP; Rego EM Cytometry B Clin Cytom; 2008 May; 74(3):163-8. PubMed ID: 18200595 [TBL] [Abstract][Full Text] [Related]
12. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones. Al-Mawali A; Gillis D; Lewis I J Hematol Oncol; 2016 Jul; 9(1):61. PubMed ID: 27465508 [TBL] [Abstract][Full Text] [Related]